KM Financial Solutions | Italy’s Dompe Farmaceutici mulls listing as part of shift to biotech
33507
post-template-default,single,single-post,postid-33507,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Italy’s Dompe Farmaceutici mulls listing as part of shift to biotech

Italy’s Dompe Farmaceutici mulls listing as part of shift to biotech

Family-owned Italian
biopharmaceutical group Dompe Farmaceutici is considering a
listing of its shares as it looks to focus more on its biotech
business and treating specific diseases.

No Comments

Sorry, the comment form is closed at this time.